| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $14.2M | $10.7M | $8.1M |
| YoY Revenue Growth % | +32.6% | +31.9% | — |
| Gross Profit | $3.1M | $3.7M | — |
| Gross Margin % | 21.9% | 34.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$3.4M | -$2.8M | -$2.8M |
| Operating Margin % | -24.2% | -25.9% | -34.6% |
| Net Income (GAAP) | -$2.7M | -$2.8M | -$2.8M |
| EBITDA (Normalized) | -$3.3M | -$2.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$1.7M | -$2.2M | -$2.9M |
| Capital Expenditures (CapEx) | $123.0K | $53.0K | — |
| Free Cash Flow (FCF) | -$1.8M | -$2.3M | -$2.9M |
| FCF Margin % | -12.6% | -21.3% | -36.2% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $470.0K | $124.0K | — |
| Total Stockholders' Equity | $1.3M | $578.0K | — |